Ratification Date: 01/04/2025
Next Review Date: 01/04/2027
Lithium – Treatment and prophylaxis of mania, bipolar disorder, and recurrent depression; aggressive or self-mutilating behaviour
Drug Name (Brand) | Lithium (Various – prescribe branded only) | |||
Indication | Treatment and prophylaxis of mania, bipolar disorder, and recurrent depression; aggressive or self-mutilating behaviour | |||
Traffic Light Classification | ADVICE | |||
NICE TA (plus link) | ||||
Further Information:
NICE recommendations, summary of meeting discussions, links to additional supporting docs etc.
Ensure that the patient is routinely monitored for serum lithium concentration and thyroid function.
Prescribe by brand only.
|
||||
Date of TAG recommendation / ratification | 4/1/2005 | Review Date | 1/4/2027 |